ENDPOINTS

Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025 

Google’s bet on AI in drug discovery just got a lot bigger. Isomorphic Labs said Monday it raised $600 million from Thrive Capital, GV, and Alphabet in its first external financing. The raise is the ...

Mar 31, 2025 - 15:52
 0
Alphabet’s Isomorphic Labs raises $600M in biotech’s largest round of 2025 
Google’s bet on AI in drug discovery just got a lot bigger. Isomorphic Labs said Monday it raised $600 million from Thrive Capital, GV, and Alphabet in its first external financing. The raise is the ...
Read More

Tags:

Previous Article

Inspirna, which was preparing for a Phase 3 cancer trial, has folded

Next Article

LifeMine’s restructuring; Europe won’t renew authorization for PTC’s Duchenne drug

Related Posts

Pharma-backed Mission Therapeutics stops preclinical operations, focuses on two clinical assets

Pharma-backed Mission Therapeutics stops preclinical op...

Feb 27, 2025  0

Epicrispr raises $68M, will start clinical trial of epigenetic editing for FSHD

Epicrispr raises $68M, will start clinical trial of epi...

Mar 26, 2025  0

Q&A: Isomorphic Labs CEO Demis Hassabis on $600M raise, AI biotech's future

Q&A: Isomorphic Labs CEO Demis Hassabis on $600M raise,...

Apr 1, 2025  0